Home
Clinical Trials
Partnerships
Contact Us
News
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Our Science and Technology
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Our Science and Technology
News and Resources
News
Posters
Videos
Publications
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
CMV News and Insights
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop
Categories:
Conferences
,
Cytomegalovirus ("CMV")
,
Glioblastoma ("GBM")
,
Press Releases
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
Categories:
Cytomegalovirus ("CMV")
,
Glioblastoma ("GBM")
,
Hepatitis B
,
Press Releases
,
Sci-B-Vac®
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
Categories:
Cytomegalovirus ("CMV")
,
Glioblastoma ("GBM")
,
Press Releases
,
Sci-B-Vac®
VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
Categories:
Conferences
,
Cytomegalovirus ("CMV")
,
Press Releases
VBI Vaccines to Present at The World Vaccine Congress Europe 2017 in Barcelona
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
,
Zika
Developing Vaccine to Prevent Birth Defects from Cytomegalovirus
Categories:
Cytomegalovirus ("CMV")
,
Media Mentions
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
Categories:
Conferences
,
Cytomegalovirus ("CMV")
,
eVLP Platform
,
Press Releases
The State of U.S. CMV Legislation in 2017
Categories:
Cytomegalovirus ("CMV")
Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome
Categories:
Cytomegalovirus ("CMV")
VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
Researchers Assess Outcomes Following Passage of Utah CMV Legislation
Categories:
Cytomegalovirus ("CMV")
Researchers Explore Possible Link Between CMV and Acute Lymphocytic Leukemia (“ALL”)
Categories:
Cytomegalovirus ("CMV")
VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of its Preventative Cytomegalovirus Vaccine Candidate
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
VBI Vaccines to Present at the Vaccine Congress
Categories:
Conferences
,
Cytomegalovirus ("CMV")
,
Press Releases
VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
Researchers Explore Possible Link Between CMV and Alzheimer’s Disease
Categories:
Cytomegalovirus ("CMV")
Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development
Categories:
Cytomegalovirus ("CMV")
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
Categories:
Cytomegalovirus ("CMV")
,
Press Releases
Page 1 of 4
1
2
3
4
›
Browse by Year
View All ›
2021 ›
2020 ›
2019 ›
2018 ›
2017 ›
2016 ›
2015 ›
2014 ›